Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (8)

2022

  1. Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1272-1281

  2. Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3

  3. Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain

    Microorganisms, Vol. 10, Núm. 4

  4. Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection

    Frontiers in Microbiology, Vol. 12

  5. The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection

    Scientific Reports, Vol. 12, Núm. 1

2020

  1. Presence of bacterial DNA in thrombotic material of patients with myocardial infarction

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Reporting identification of Acinetobacter spp genomic species: A nationwide proficiency study in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 2, pp. 89-92

2018

  1. Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: A nationwide proficiency study

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 3, pp. 692-697